EDQM 宣布 2027 年 6 月 8-9 日举办 PhageConnect 研讨会
SAVE THE DATE! EDQM Symposium ‘PhageConnect’ (8-9 June 2027)
EDQM 宣布将于 2027 年 6 月 8-9 日在法国斯特拉斯堡举办 PhageConnect 研讨会,聚焦噬菌体治疗药品(PTMPs)质量控制。欧洲药典委员会已通过通则 5.31(2024 年 3 月)和 2.7.38(2026 年 3 月),为 PTMPs 的表征、质量控制和检测提供框架。会议将汇集监管方、开发方、控制实验室等,讨论噬菌体鉴定、基因组变异管理、效价测定及标准缺口。
SAVE THE DATE! EDQM Symposium ‘PhageConnect’ (8-9 June 2027)
EDQM Strasbourg, France 10/11/2026

The EDQM is pleased to announce the symposium PhageConnect, which will take place in Strasbourg (France) on 8 and 9 June 2027.
Bacteriophages are attracting increasing global interest as a promising approach to addressing unmet medical needs, particularly in the fight against antimicrobial resistance. As phage therapy moves closer to broader clinical implementation, establishing appropriate quality standards, regulatory frameworks and analytical approaches is essential to support the development of safe, effective and high-quality phage therapy medicinal products (PTMPs).
Recognising this need, the European Pharmacopoeia Commission (EPC) has played a leading role in developing pharmacopoeial standards for phage therapy. The adoption by the EPC of the general chapters 5.31.Phage therapy medicinal products in March 2024 and 2.7.38.Bacteriophage potency determination in March 2026 marked a significant milestone, providing a comprehensive framework for the characterisation, quality control and testing of PTMPs.
PhageConnect will bring together regulators, developers, control laboratories and other stakeholders from Europe and beyond to discuss the challenges for the quality control of PTMPs. The event will also provide a unique opportunity to identify remaining gaps in standards and discuss future priorities for the European Pharmacopoeia in supporting innovation and facilitating patient access to high-quality and safe phage therapies.
Through a series of interactive sessions, participants will be invited to share practical experience and perspectives on key scientific and regulatory challenges. Topics for discussion will include phage identity testing, the management and control of genomic variability, approaches to potency determination and areas where further guidance or standardisation may be beneficial.
Save the date and join the conversation helping to shape the future of phage quality standards and phage therapy in Europe and beyond.
Stay tuned – more information available soon!
来源:EDQM 官方新闻与欧洲药典公告 · edqm.eu